inactive

Nimenrix®

Meningococcal A,C,Y,W135 conjugate vaccine

Nimenrix® is a meningococcal A,C,Y,W-135 conjugate vaccine used to protect against four groups of Neisseria meningitidis, group A, group C, group Y and group W-135.

Nimenrix® is used as an alternative vaccine to the meningococcal C conjugate vaccine (Neisvac-C™), meningococcal A,C,Y,W-135 conjugate vaccine (Menactra®) and the meningococcal A,C,Y,W-135 polysaccharide vaccine (Mencevax® ACYW).

The conjugate and polysaccharide vaccines work differently to generate protection against the bacteria. Protection from the conjugate vaccines lasts longer than that from the polysaccharide vaccines. The conjugate vaccines also generate long term memory cells allowing rapid boosting of immunity years later.

IPOL

IPV

IPOL is used for primary and booster vaccination of infants, children and adults to protect against infection with Type 1, Type 2 and Type 3 polioviruses causing poliomyelitis.

Menomune® ACYW-135

Meningococcal A,C,Y,W135 polysaccharide vaccine

There are no supplies of Menomune® currently in New Zealand. Menactra® and Nimenrix® are alternative vaccine brands. Menomune® is used for vaccination of children two years of age and over and adults to protect against four groups of Neisseria meningitidis, group A, group C, group Y and group W-135.

Act-HIB®

Haemophillus influenzae type b (Hib)

Act-HIB® is used for a booster vaccination at 15 months of age to protect against disease caused by Haemophilus influenzae type b. The vaccine is also used for vaccination of children aged 5 years of age and over and adults with some chronic medical conditions.

ADT™ Booster

Td

ADT™ Booster is used for primary and booster vaccination of children 7 years of age and over and adults to protect against tetanus and diphtheria. An alternative vaccine called Boostrix®, which protects against tetanus, diphtheria and pertussis (whooping cough), can be substituted for one, two or all three doses of the primary vaccinations in these age groups. Both ADT™ Booster and Boostrix® are licensed as booster vaccines. They are used for primary vaccination out of licensure as there is no alternative primary vaccination strength vaccine available in New Zealand for these age groups. When the vaccine is used for a primary vaccination course, use will be outside of current licensure. No safety concerns are expected with use in these circumstances.

Infanrix®-IPV

DTaP-IPV

Infanrix®-IPV is used for primary and booster vaccination of infants and children to protect against diphtheria, tetanus, pertussis and poliomyelitis. Infanrix®-IPV can also be used for catch-up immunisation for children up to their 10th birthday.

Gardasil®

Human papillomavirus (HPV)

Gardasil® protects against four types of human papillomavirus (HPV) infection. HPV types 6 and 11 cause anogenital warts and HPV types 16 and 18 cause precancerous lesions, mouth, throat, cervical, vaginal, vulvar, penile and anal cancers.

Synflorix®

PCV10

Synflorix® is used for primary and booster vaccination of infants and children up to their 5th birthday to protect against disease caused by 10 types of streptococcus pneumoniae.

Pages

Subscribe to RSS - inactive